XORTX Therapeutics, Inc. XRTX
NASDAQ · United States · Health Technology
$1.73+0.04 (+2.37%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-17 | -1.05 | — | — | -5.0%$2.15→$2.05 |
| Q3 2025 | 2025-11-14 | -1.02 | -1.58 | +35.4% | -4.1%$2.80→$2.68 |
| Q4 2024 | 2025-03-25 | -1.17 | -2.08 | +43.8% | — |
| Q2 2024 | 2024-08-14 | -3.44 | -4.61 | +25.4% | — |
| Q1 2024 | 2024-05-15 | -2.96 | -4.21 | +29.7% | — |
| Q4 2023 | 2024-04-02 | -3.18 | -4.07 | +21.9% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.